ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 223 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $66,910 | -39.9% | 12,277 | -2.7% | 0.00% | – |
| Q1 2023 | $111,364 | +16.9% | 12,612 | +1.1% | 0.00% | – |
| Q4 2022 | $95,286 | -27.8% | 12,472 | -32.8% | 0.00% | – |
| Q3 2022 | $132,000 | -31.6% | 18,571 | -22.3% | 0.00% | -100.0% |
| Q2 2022 | $193,000 | -48.0% | 23,907 | +80.7% | 0.00% | 0.0% |
| Q4 2021 | $371,000 | -20.0% | 13,232 | -3.0% | 0.00% | 0.0% |
| Q3 2021 | $464,000 | -12.6% | 13,643 | +5.0% | 0.00% | 0.0% |
| Q2 2021 | $531,000 | +36.5% | 12,994 | +34.4% | 0.00% | 0.0% |
| Q1 2021 | $389,000 | -32.8% | 9,668 | -1.3% | 0.00% | 0.0% |
| Q4 2020 | $579,000 | +16.5% | 9,798 | -4.1% | 0.00% | 0.0% |
| Q3 2020 | $497,000 | +10.0% | 10,218 | +9.3% | 0.00% | 0.0% |
| Q2 2020 | $452,000 | +79.4% | 9,348 | +3.2% | 0.00% | 0.0% |
| Q1 2020 | $252,000 | – | 9,058 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
| Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
| Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
| Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
| TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
| Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
| Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
| Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
| Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |